Clover Health Investments, Corp. (CLOV) vs Nurix Therapeutics, Inc. (NRIX)

A side-by-side comparison of Clover Health Investments, Corp. and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLOV vs NRIX

growth of $100 · dividends reinvested · last 6y
CLOV -57.0% (-13.1%/yr)NRIX +20.4% (+3.1%/yr)NRIX compounded faster over this window
0100200Start $100202120222023202420252026$43$120
CLOV NRIX

CLOV vs NRIX: by the numbers

  • •CLOV is the larger company ($2.41B vs $2.36B market cap).
  • •Both run net losses; CLOV's is the smaller (-0.74% vs -928.44% net margin).
  • •CLOV grew revenue faster over the past five years (21.18% vs 9.96% CAGR).

Metrics side by side

Valuation

MetricCLOVNRIX
Forward P/E82.89N/A
P/S ratio0.9764.22
P/B ratio6.405.86
FCF yield3.08%N/A

Profitability

MetricCLOVNRIX
Gross margin18.57%77.55%
Operating margin-0.74%-340.16%
Net margin-0.74%-928.44%
ROE-4.88%-84.78%
ROIC-4.62%-77.92%

Growth (annualized)

MetricCLOVNRIX
Revenue CAGR (5Y)21.18%9.96%
Total return CAGR (5Y)-8.36%-5.51%

Frequently asked

Which has grown faster, CLOV or NRIX?
Over the past five years, CLOV grew revenue faster — CLOV at a 21.18% CAGR versus NRIX at 9.96%.
How have CLOV and NRIX total returns compared?
Over the past 5 years, CLOV delivered -8.36% and NRIX delivered -5.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.